KCNC3
potassium voltage-gated channel, Shaw-related subfamily, member 3 | |
---|---|
Identifiers | |
Symbol | KCNC3 |
Alt. symbols | SCA13 |
Entrez | 3748 |
HUGO | 6235 |
OMIM | 176264 |
RefSeq | NM_004977 |
Other data | |
Locus | Chr. 19 q13.33 |
WikiDoc Resources for KCNC3 |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on KCNC3 at Clinical Trials.gov Clinical Trials on KCNC3 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on KCNC3
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating KCNC3 Risk calculators and risk factors for KCNC3
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
KCNC3 is a gene encoding the voltage-gated potassium channel protein Kv3.3. KCNC3 is associated with spinocerebellar ataxia type 13.
See also
External links
- "Voltage-Gated Potassium Channels: Kv3.3". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.